Research team led by Case Western Reserve awarded $2.75M from Department of Defense to advance clot-stabilizing nanotechnology

The U.S. Department of Defense (DoD) has awarded a team of researchers led by Case Western Reserve University a four-year, $2.75 million grant to explore new technology to generate and stabilize a protein called fibrin that is essential to maintain protective blood clots in an injured body.

Prevent BLEEDing Act introduced in Congress will advance STOP THE BLEED® efforts

The American College of Surgeons (ACS) applauds Senators Menendez and Boozman and Representatives O’Halleran and Wenstrup for introducing the Prevent Blood Loss with Emergency Equipment Devices Act (Prevent BLEEDing Act). This legislation is crucial to support efforts to bring STOP THE BLEED® training and equipment directly to all U.S. citizens.

Giving Trauma Patients a Hormone that Helps Stabilize Blood Pressure Cuts Blood Transfusions by Half

Giving trauma patients with severe blood loss the hormone arginine vasopressin (AVP) cut the volume of blood products required to stabilize them by half, according to results of a new, first-of-its-kind clinical trial from Penn Medicine. The authors say the study is particularly important for the treatment of patients with gun-related injuries. Each year, there are over 100,00 firearm-related injuries with over 36,000 deaths.